High Katherine A 4

What Happened Katherine A. High, a director of Incyte Corporation, received two equity awards on 2026-06-08: 1,642 restricted stock units (RSUs) and a derivative award of 6,111 shares (reported as a derivative/option). Both grants were reported at an acquisition price of $0.00 (total reported value $0 at grant); economic value depends on Incyte’s future stock price. These are grants (compensation), not open-market purchases or sales.

Key Details

• Transaction date: 2026-06-08; Form 4 filed 2026-06-10 (filed two days after the transaction, which is generally timely under Form 4 rules).
• Grants: 1,642 RSUs @ $0.00 (acquired); 6,111 derivative award/option @ $0.00 (acquired). Reported total consideration: $0.
• Vesting/settlement: Per footnotes, the RSUs vest in full on the first anniversary of grant or earlier at the next regular annual meeting or upon a change in control; RSUs settle one-for-one for common stock (F1). The derivative award/option likewise vests in full on the first anniversary (or earlier at the next annual meeting or change in control) (F3).
• Footnote F2 notes that, including this grant, there is an aggregate of 1,642 shares issuable pursuant to previously reported unvested RSUs.
• Shares owned following the transaction: not specified in the provided filing excerpt.

Context These awards are standard director compensation and are not an immediate purchase signal — the RSUs and option-like derivative must vest (typically about one year) before converting to shares. No shares were sold or exercised in this filing, and there’s no indication of a cashless exercise or immediate disposition.